Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Portfolio · 30 Jun 2026
From the fund’s own N-PORT filingThe fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 161 positions. The ten largest identified positions carry 17.9% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | State Street Global Advisors | — | United States | 5.87% | $630.64M |
| 2 | Apogee Therapeutics Inc | — | United States | 1.48% | $159.76M |
| 3 | Moderna Inc MRNA | Healthcare | United States | 1.41% | $151.60M |
| 4 | Twist Bioscience Corp TWST | Healthcare | United States | 1.40% | $151.14M |
| 5 | Oruka Therapeutics Inc ORKA | Healthcare | United States | 1.37% | $147.98M |
| 6 | Kymera Therapeutics Inc KYMR | Healthcare | United States | 1.35% | $145.94M |
| 7 | Viking Therapeutics Inc VKTX |
Source: SEC filings. Information and analytics, not investment advice.